Form 4 for OFIX Orthofix Medical Inc.
Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-03 · accession 0000950170-25-033593 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-05 | 2025-03-03 | OFIX | Calafiore Massimo | Pres, CEO, Dir | A - Grant | $0.00 | +88.3K | 212.5K | +71% | $0 |
| D | 2025-03-05 | 2025-03-03 | OFIX | Calafiore Massimo | Pres, CEO, Dir | A - Grant | $0.00 | +209.5K | 209.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-03 | A | A | 88,339 | $0.00 | 212,490 | D | — | — | (F1) The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date. (F2) Includes 94,057 previously reported restricted stock units. |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2025-03-03 | A | A | 209,541 | $0.00 | 209,541 | D | $16.98 · — to 2032-03-03 | 209,541 Common Stock | (F3) The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date. |